Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.

Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.

Item
http://www.wikidata.org/entity/Q30559082
Stabilizing Agents for Drug Nanocrystals: Effect on BioavailabilityEffect of cyclodextrin complexation on the aqueous solubility and solubility/dose ratio of praziquantel.Formulation, characterization and pharmacokinetics of praziquantel-loaded hydrogenated castor oil solid lipid nanoparticles.Cyclodextrins in drug delivery: an updated reviewPraziquantel in a clay nanoformulation shows more bioavailability and higher efficacy against murine Schistosoma mansoni infection.Exploring versatile applications of cyclodextrins: an overview.Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release.Preparation and Evaluation of Silymarin β-cyclodextrin Molecular Inclusion Complexes.Efficacy of bath and orally administered praziquantel and fenbendazole against Lepidotrema bidyana Murray, a monogenean parasite of silver perch, Bidyanus bidyanus (Mitchell).Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin.Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation.β-Cyclodextrin polymer binding to DNA: Modulating the physicochemical parameters.Effects of inclusion of cetirizine hydrochloride in β-cyclodextrinEffect of hydroxypropyl methylcellulose on beta cyclodextrin complexation of praziquantel in solution and in solid stateIntestinal Lymphatic Delivery of Praziquantel by Solid Lipid Nanoparticles: Formulation Design,In VitroandIn VivoStudies
P2860

Improvement of the in vitro dissolution of praziquantel by complexation with alpha-, beta- and gamma-cyclodextrins.

Item
http://www.wikidata.org/entity/Q30559082
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@ast
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@en
type
label
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@ast
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@en
prefLabel
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@ast
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Improvement of the in vitro di ...... beta- and gamma-cyclodextrins.
@en
P2093
P304
P31
P356
10.1016/S0378-5173(98)00382-2
P407
P433
P478
P577
P698